Cardinal Health (NYSE:CAH) has tumbled 3.85% during the past week and has dropped 2.45% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 2.69%. Cardinal Health (NYSE:CAH) has underperformed the index by 3.34% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Cardinal Health (NYSE:CAH): The stock opened at $76.56 on Friday but the bulls could not build on the opening and the stock topped out at $76.57 for the day. The stock traded down to $75.37 during the day, due to lack of any buying support eventually closed down at $75.51 with a loss of -1.35% for the day. The stock had closed at $76.54 on the previous day. The total traded volume was 2,897,455 shares.
The company shares have dropped -15.97% from its 1 Year high price. On Dec 29, 2015, the shares registered one year high at $91.23 and the one year low was seen on Feb 8, 2016. The 50-Day Moving Average price is $78.02 and the 200 Day Moving Average price is recorded at $82.00.
On the companys insider trading activities,The officer (Chief HR Officer) of Cardinal Health Inc, Watkins Carole S sold 84,617 shares at $77.33 on May 20, 2016. The Insider selling transaction had a total value worth of $6,543,433. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Many analysts have stated their opinion on the company shares. Equity analysts at the Brokerage firm Bank of America reinstates its rating on Cardinal Health (NYSE:CAH). The rating major has initiated the coverage with neutral rating on the shares. The rating by the firm was issued on June 7, 2016. Currently the company Insiders own 0.97% of Cardinal Health shares according to the proxy statements. Institutional Investors own 86.35% of Cardinal Health shares.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.